Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
SUMMARY The tumor-suppressive Hippo pathway controls tissue homeostasis through balancing cell proliferation and apoptosis. Activation of the kinases Mst1/2 is a key upstream event in this pathway and remains poorly understood. Mst1/2 and their critical regulators RASSFs contain SARAH domains that can homo- and hetero-dimerize. Here, we report the crystal structures of human Mst2 alone and bound to RASSF5. Mst2 undergoes activation through trans-autophosphorylation at its activation loop, which requires SARAH-mediated homodimerization. RASSF5 disrupts Mst2 homodimer and blocks Mst2 autoactivation. Binding of RASSF5 to already activated Mst2, however, does not inhibit its kinase activity. Thus, RASSF5 can act as an inhibitor or a potential positive regulator of Mst2, depending on whether it binds to Mst2 before or after activation-loop phosphorylation. We propose that these temporally sensitive functions of RASSFs enable the Hippo pathway to respond to and integrate diverse cellular signals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Overview of the CCP 4 suite and current developments
Winn, M. D., Ballard, C. C., Cowtan, K. D., Dodson, E. J., Emsley, P., Evans, P. R., Keegan, R. M., Krissinel, E. B., Leslie, A. G. W., McCoy, A., et al. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910045749 · Cited by 12,353
Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092 · cited 2×
“In the canonical Hippo kinase cascade, Mst1/2, in complex with Sav1, phosphorylate and activate the Lats1/2-Mob1 complexes, which then phosphorylate the transcriptional coactivator Yes-associated protein (YAP), a major downstream target of the Hippo pathway (Dong et al., 2007; Hao et al., 2008; Hong and Guan, 2012; Hu…”
Self-citationTEAD mediates YAP-dependent gene induction and growth control
Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M., et al. (2008) · Genes & Development · doi:10.1101/gad.1664408 · Cited by 2,498
Self-citationA coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF β-TRCP
Zhao, B., Li, L., Tumaneng, K., Wang, C.-Y., & Guan, K.-L. (2010) · Genes & Development · doi:10.1101/gad.1843810 · Cited by 1,418 · cited 1×
“Phosphorylation of YAP at S381 by Lats1/2 promotes its ubiquitination and degradation (Zhao et al., 2010b).”
The Salvador–Warts–Hippo pathway — an emerging tumour-suppressor network
Harvey, K., & Tapon, N. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2070 · Cited by 628 · cited 1×
“This tumor-suppressive pathway was first characterized in Drosophila through genetic screens for mutations that caused tissue overgrowth and was later shown to be conserved in mammals (Badouel et al., 2009; Edgar, 2006; Halder and Johnson, 2011; Harvey and Tapon, 2007; Harvey et al., 2013; Pan, 2010; Staley and Irvine…”
Cited by
Mechanisms of Hippo pathway regulation
Meng, Z., Moroishi, T., & Guan, K.-L. (2016) · Genes & Development · doi:10.1101/gad.274027.115 · Cited by 1,667
The Hippo Signaling Pathway in Development and Disease
Zheng, Y., & Pan, D. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.06.003 · Cited by 867
“, 2017), the RASSF family proteins preclude autoactivation by forming RASSF-Hpo/MST heterodimers (Ni et al., 2013; Praskova et al., 2004).”
BackgroundSelf-citationPharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration
Fan, F., He, Z., Kong, L.-L., Chen, Q., Yuan, Q., Zhang, S., Ye, J., Liu, H., Sun, X., Geng, J., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf2304 · Cited by 382
Zheng, Y., Liu, B., Wang, L., Lei, H., Pulgar Prieto, K. D., & Pan, D. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.076 · Cited by 110
“Activation of Hpo and its mammalian homologues MST1/2 requires phosphorylation of a key site in the activation loop of the kinase domain (T195 for Hpo, T183/T180 for MST1/2), which can be mediated by trans-autophosphorylation (Creasy et al., 1996; Ni et al., 2013; Praskova et al., 2004) or by an upstream kinase Tao-1…”
BackgroundSelf-citationWong, K.-F., Liu, A. M., Hong, W., Xu, Z., & Luk, J. M. (2016) · Oncotarget · doi:10.18632/oncotarget.12760 · Cited by 63
Metadata
- Authors
- Ni, L., Li, S., Yu, J., Min, J., Brautigam, C. A., Tomchick, D. R., Pan, D., & Luo, X.
- Venue
- Structure
- Publisher
- Elsevier BV
- Published
- 2013-10
- Volume
- 21
- Issue
- 10
- Pages
- 1757-1768
- ISSN
- 0969-2126 (ISSN-L)
- OpenAlex
- W2021830999
- Cited by
- 94
- References
- 5
- FWCI
- 4.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5. https://app.cochat.ai/papers/10.1016/j.str.2013.07.008
- The paper
- Ni, L., Li, S., Yu, J., Min, J., Brautigam, C. A., Tomchick, D. R., Pan, D., & Luo, X. (2013). Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5. Structure. https://doi.org/10.1016/j.str.2013.07.008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.